Cysteine-rich protein (CRP)

Cysteine-rich proteins (CRPs) constitute a diverse group of proteins defined by their high cysteine content and the presence of multiple disulfide bonds, which are critical for their structural and functional integrity. This category includes several distinct families, such as the chlamydial outer membrane complex proteins (e.g., MOMP, OmcA, and OmcB), which provide structural rigidity to the pathogen and serve as targets for vaccine development (NIH, 2019). In human physiology, the term encompasses mucins, which are targeted by mucolytic agents like N-acetylcysteine to reduce mucus viscosity in respiratory diseases, and metallothioneins, which regulate metal homeostasis and redox balance (MDPI, 2023). Additionally, specific families like the LIM-domain-containing cysteine-rich proteins (CRIP1, CRIP2) are involved in cytoskeletal organization and have been implicated in cancer progression. Cysteine-rich secretory proteins (CRISPs) are also found in mammalian reproductive systems and various animal venoms, where they modulate ion channel activity (Wikipedia, 2024). Because the term Various cysteine-rich proteins refers to a broad structural class rather than a single molecular entity, it is often used in pharmacology to describe the collective targets of thiol-reactive or disulfide-disrupting drugs. Consequently, therapeutic strategies targeting these proteins are frequently characterized by a lack of molecular specificity, acting instead on the common chemical properties of the cysteine-rich domains (ResearchGate, 2019).

Other names

Cysteine-rich proteinsCRPsCysteine-rich domain-containing proteinsCysteine-rich secretory proteinsMetallothioneinsMucinsVarious cysteine-rich proteins

Drugs targeting these proteins typically act by reducing disulfide bonds, chelating metal ions, or covalently modifying cysteine residues.